Caribou Biosciences (CRBU) Insider Trading & Ownership $1.31 -0.03 (-2.24%) Closing price 01/30/2025 04:00 PM EasternExtended Trading$1.34 +0.03 (+2.29%) As of 01/30/2025 07:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Caribou Biosciences (NASDAQ:CRBU) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage9.50%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$24,651.20Number OfInsiders Selling(Last 12 Months)0 Get CRBU Insider Trade Alerts Want to know when executives and insiders are buying or selling Caribou Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CRBU Insider Buying and Selling by Quarter Caribou Biosciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/29/2025Sriram RyaliCFOBuy17,360$1.42$24,651.20 (Data available from 1/1/2013 forward) CRBU Insider Trading Activity - Frequently Asked Questions Who is on Caribou Biosciences's Insider Roster? The list of insiders at Caribou Biosciences includes Ryan Fischesser, Sriram Ryali, Steven Kanner, and Syed Ali-Aamir Rizvi. Learn more on insiders at CRBU. What percentage of Caribou Biosciences stock is owned by insiders? 9.50% of Caribou Biosciences stock is owned by insiders. Learn more on CRBU's insider holdings. Which Caribou Biosciences insiders have been buying company stock? The following insider purchased CRBU shares in the last 24 months: Sriram Ryali ($24,651.20). How much insider buying is happening at Caribou Biosciences? Insiders have purchased a total of 17,360 CRBU shares in the last 24 months for a total of $24,651.20 bought. Caribou Biosciences Key ExecutivesDr. Rachel E. Haurwitz Ph.D. (Age 38)Co-Founder, CEO, President & Director Compensation: $979.08kDr. Steven B. Kanner Ph.D. (Age 64)Chief Scientific Officer Compensation: $669.31kMs. Barbara G. McClung Esq. (Age 69)J.D., Chief Legal Officer & Corporate Secretary Compensation: $669.31kMr. Jason V. O'Byrne M.B.A. (Age 55)CFO & Principal Accounting Officer Compensation: $586.36kMr. Daniel PoonVice President of Operations & Information TechnologyMr. Timothy P. Kelly M.B.A. (Age 55)Chief Technology Officer Ms. Amy Figueroa C.F.A.Vice President of Investor Relations & Corporate CommunicationsMs. Reigin ZawadzkiChief People OfficerMs. Ruhi A. Khan M.B.A. (Age 49)Chief Business Officer Compensation: $573.9kMr. Ryan FischesserVice President of Finance & Controller More Insider Trading Tools from MarketBeat Related Companies AnaptysBio Insider Trading Xeris Biopharma Insider Trading Mind Medicine (MindMed) Insider Trading Rapport Therapeutics Insider Trading Akebia Therapeutics Insider Trading Altimmune Insider Trading Mineralys Therapeutics Insider Trading Cartesian Therapeutics Insider Trading Entrada Therapeutics Insider Trading Alpha Teknova Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Selling in Tech Stocks Spikes in Q43 Small-Cap Stocks Insiders and Institutions Are Buying3 Stocks With Strong Capital Returns and Insider Buying SignalsZymeworks in Focus for Insider Activity: Catalysts AheadInsiders Are Loading Up: 3 Key Stock Picks for Investors This page (NASDAQ:CRBU) was last updated on 1/31/2025 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored#1 Crypto of 2025Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Caribou Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Caribou Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
